MedPath

A clinical study to evaluate the effect of Unani drug in the Treatment of Chronic Cervicitis

Phase 2
Conditions
Health Condition 1: N72- Inflammatory disease of cervix uteri
Registration Number
CTRI/2024/04/065064
Lead Sponsor
Ayurvedic and Unani Tibbia college and hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Married women in the age group of 18 to 45 years having vaginal discharge.

2. Patient giving history or complaint of the passage of mucopurulent cervical discharge with or without foul smell.

3. Patient with complaints of lower backache.

4. Patient with complaints of intermenstrual spotting and post-coital bleeding.

6. Patient having symptoms of dyspareunia and dysuria.

7. Patient having complaints of vulval Itching.

8. On P/S examination there may be findings of Nabothian follicles, congestion, and hyperplasia of cervix.

Exclusion Criteria

1. The patient was unwilling to sign the consent form.

2. The patient has a history of AIDS, syphilis, gonorrhea or any other sexually transmitted disease.

3. History of cardiovascular, renal, liver disease.

4. History of diabetes mellitus .

5. Patients with systemic disease and malignancy.

6. Individuals of alcohol abuse or any other substance abuse.

7. Unmarried and pregnant women.

8. Women having a history of conisation, cryotherapy, and cauterization will also excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
VAS Score (visual analogue scale),PS/PV Examination and PAP Smear will be assessed <br/ ><br> <br/ ><br>Timepoint: 12 weeks <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Abnormal cervical discharge, <br/ ><br>Lower backache, Vulval Itching, <br/ ><br>Foul smell in Vaginal Discharge will be assessed <br/ ><br>Timepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath